Cargando…
Disease stages and therapeutic hypotheses in two decades of neurodegenerative disease clinical trials
Neurodegenerative disease is increasingly prevalent and remains without disease-modifying therapies. Engaging the right target, at the right disease stage, could be an important determinant of success. We annotated targets and eligibility criteria for 3238 neurodegenerative disease trials registered...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587287/ https://www.ncbi.nlm.nih.gov/pubmed/36271285 http://dx.doi.org/10.1038/s41598-022-21820-1 |